There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Evofem Biosciences (EVFM – Research Report), Greenwich LifeSciences (GLSI – Research Report) and Chinook Therapeutics (KDNY – Research Report) with bullish sentiments.
Evofem Biosciences (EVFM)
In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Evofem Biosciences, with a price target of $4.00. The company’s shares closed last Friday at $0.41, close to its 52-week low of $0.28.
According to TipRanks.com, Selvaraju has 0 stars on 0-5 stars ranking scale with an average return of
Evofem Biosciences has an analyst consensus of Moderate Buy, with a price target consensus of $2.56.
See the top stocks recommended by analysts >>
Greenwich LifeSciences (GLSI)
H.C. Wainwright analyst Yi Chen reiterated a Buy rating on Greenwich LifeSciences today and set a price target of $78.00. The company’s shares closed last Friday at $9.60, close to its 52-week low of $6.82.
According to TipRanks.com, Chen is ranked 0 out of 5 stars with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Greenwich LifeSciences with a $78.00 average price target.
Chinook Therapeutics (KDNY)
In a report released today, Ed Arce from H.C. Wainwright maintained a Buy rating on Chinook Therapeutics, with a price target of $32.00. The company’s shares closed last Friday at $20.64, close to its 52-week high of $21.11.
According to TipRanks.com, Arce is a 4-star analyst with an average return of
Currently, the analyst consensus on Chinook Therapeutics is a Strong Buy with an average price target of $34.40, implying a 70.1% upside from current levels. In a report issued on August 9, SVB Securities also reiterated a Buy rating on the stock with a $44.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on EVFM:
- Titanium Transportation Group Announces Appointment of Grace Palombo to Board of Directors
- Shoals Technologies Group Further Strengthens Executive Management Team With Appointment of New Chief Financial Officer
- Nordic American Tankers Ltd (NYSE: NAT) – Update on contracts
- H.C. Wainwright Remains a Hold on Metacrine (MTCR)
- H.C. Wainwright Sticks to Its Hold Rating for Iterum Therapeutics (ITRM)
